Supernus Pharmaceuticals | SUPN - EPS Earnings Per Share

Stock Price
49.76
Daily Change
-0.63 -1.25%
Monthly
-0.60%
Yearly
54.44%
Q2 Forecast
48.70

Supernus Pharmaceuticals reported $-0.07 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04
FY2025Q2 Jun/2025 0.40 0.46 0.77 Aug/05
FY2025Q1 Mar/2025 -0.21 0.37 0.26 May/06




Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.05 0.03 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025